Ex vivo reversal of effects of rivaroxaban evaluated using thromboelastometry and thrombin generation assay
Bettina Schenk(Apple (Israel)), Mirjam Bachler(Innsbruck Medical University), Wolfgang Sturm(Innsbruck Medical University), Philipp Würtinger(Ludwig Boltzmann Institute Applied Diagnostics), D Friès(Innsbruck Medical University), Werner Streif(Innsbruck Medical University)
Cited by 29
Related Papers
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
|The Lancet Haematology|2019|329
The analysis of healthy volunteers' exhaled breath by the use of solid-phase microextraction and GC-MS
|Journal of Breath Research|2008|152
Impaired fibrinolysis in critically ill COVID-19 patients
|British Journal of Anaesthesia|2020|117